title: Significance of Kampo, Japanese traditional medicine, in the treatment of obesity: basic and clinical evidence.
abstract: The cause of obesity includes genetic and environmental factors, including cytokines derived from adipocytes (adipo-cytokines). Although drug therapy is available for obesity, it is highly risky. Our main focus in this review is on the traditional form of Japanese medicine, Kampo, in the treated of obesity. Two Kampo formulas, that is, bofutsushosan () and boiogito (), are covered by the national health insurance in Japan for the treatment of obesity. Various issues related to their action mechanisms remain unsolved. Considering these, we described the results of basic experiments and presented clinical evidence and case reports on osteoarthritis as examples of clinical application of their two Kampo medicine. Traditional medicine is used not only for treatment but also for prevention. In clinical practice, it is of great importance to prove the efficacy of combinations of traditional medicine and Western medicine and the utility of traditional medicine in the attenuation of adverse effects of Western medicine.
authors: Department of General Medicine, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Kahoku District Ishikawa 920-0293, Japan.
authors: Jun-Ichi
authors: J
authors: Yamakawa
authors: Junji
authors: J
authors: Moriya
authors: Kenji
authors: K
authors: Takeuchi
authors: Mio
authors: M
authors: Nakatou
authors: Yoshiharu
authors: Y
authors: Motoo
authors: Junji
authors: J
authors: Kobayashi
references: Diabetes. 2013 May;62(5):1709-17
references: 23328126
references: J Obes. 2011;2011:432607
references: 21773005
references: World Rev Nutr Diet. 2005;94:1-12
references: 16145245
references: Diabetes. 1981;30(Suppl 2):66-75
references: 7028540
references: Metabolism. 1990 Oct;39(10):1044-8
references: 2215252
references: In Vivo. 2005 Nov-Dec;19(6):1029-33
references: 16277017
references: J Altern Complement Med. 2009 Mar;15(3):267-74
references: 19292654
references: Mo Med. 2003 May-Jun;100(3):248-55
references: 12847866
references: Lancet. 2008 Feb 16;371(9612):555-6; author reply 556-7
references: 18280321
references: Psychiatr Clin North Am. 2011 Dec;34(4):871-80
references: 22098810
references: J Ethnopharmacol. 2007 Jan 19;109(2):236-40
references: 16962271
references: Mediators Inflamm. 2010;2010:802078
references: 20671929
references: Curr Opin Pharmacol. 2013 Apr;13(2):200-4
references: 23332347
references: Clin Exp Pharmacol Physiol. 2004 Sep;31(9):614-9
references: 15479169
references: Biol Pharm Bull. 2008 Nov;31(11):2083-9
references: 18981578
references: Biol Pharm Bull. 2008 Jul;31(7):1362-7
references: 18591775
references: Evid Based Complement Alternat Med. 2004 Jun 1;1(1):11-16
references: 15257321
references: Nat Rev Drug Discov. 2012 Sep;11(9):675-91
references: 22858652
references: Lancet. 2007 Nov 17;370(9600):1706-13
references: 18022033
references: Expert Opin Investig Drugs. 2002 Sep;11(9):1189-204
references: 12225242
references: Evid Based Complement Alternat Med. 2004 Sep 1;1(2):119-123
references: 15480437
references: Heart. 2011 Jul;97(14):1143-50
references: 21610270
references: Am J Health Syst Pharm. 2001 Jul 15;58(14):1301-8
references: 11471477
references: Eur Heart J. 1987 May;8 Suppl B:45-55
references: 3038555
references: Int J Obes Relat Metab Disord. 2002 May;26(5):590-2
references: 12032740
references: Sports Med Arthrosc Rehabil Ther Technol. 2012 Jan 10;4:3
references: 22230247
references: Circulation. 2013 Jan 1;127(1):74-85
references: 23186644
references: Evid Based Complement Alternat Med. 2011;2011:931073
references: 19208721
references: Lancet. 2010 Aug 14;376(9740):517-23
references: 20709233
references: Diabete Metab. 1987 Jul;13(3 Pt 2):331-6
references: 3115843
references: J Clin Biochem Nutr. 2008 Mar;42(2):158-66
references: 18385834
references: Evid Based Complement Alternat Med. 2010 Mar;7(1):87-95
references: 18955282
references: Psychopharmacology (Berl). 2009 Jul;205(1):171-4
references: 19300982
references: Diabete Metab. 1991 May;17(1 Pt 2):96-100
references: 1936490
references: Obesity (Silver Spring). 2013 Jan;21(1):E154-61
references: 23505198
references: Int J Obes Relat Metab Disord. 1995 Oct;19(10):717-22
references: 8589765
references: Hypertension. 1991 Sep;18(3 Suppl):I95-107
references: 1889862
references: Curr Opin Endocrinol Diabetes Obes. 2011 Oct;18(5):321-7
references: 21878755
references: World J Gastroenterol. 2009 Jul 7;15(25):3073-85
references: 19575486
references: Gastroenterol Clin North Am. 2010 Mar;39(1):69-79
references: 20202580
references: Evid Based Complement Alternat Med. 2004 Dec;1(3):219-222
references: 15841254